QLT Inc. (QLTI) Acquires OT-730 Beta Blocker from Othera Pharmaceuticals
Tweet Send to a Friend
QLT Inc. (NASDAQ: QLTI) today announced that the Company has acquired OT-730, a prodrug of a beta adrenergic antagonist (a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
